Global Vaccine Contract Manufacturing Market Worth $1251m in 2021

Monday 3 April 2017, Amsterdam

This new report, now available on ASDReports, Global Vaccine Contract Manufacturing Market Report 2017-2027: Leading Countries, Technologies and Companies indicates that the global vaccine contract manufacturing market will see $1251m in spending in 2021.

The global vaccine contract manufacturing market is expected to grow at a CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from 2021-2027. The market is expected to grow at a CAGR of 9.1% from 2016 to 2027. The market is estimated at $816m in 2016, and $2117m in 2027.

The lead analyst of the report said: “The vaccine manufacturing technology and services market has experienced considerable growth over the past decade. Vaccines are a global healthcare success, currently driven by disease burden and the expanding global population. Paediatric vaccines will continue to be the leading market segment. Strong growth will be seen in the therapeutic vaccines market, driven by development of vaccines for indications such as cancer. Our research suggests that demand and technological developments in this industry will drive changes in the methods and management of vaccine production. The global vaccine market will experience strong growth throughout the forecast period, as will that for outsourced vaccine manufacturing.

Vaccine manufacturing is highly technical with stringent regulatory and quality standards which have mainly kept it within regions which have the technology and regulatory framework to accommodate production. Although off-shoring to lower costs is very popular for other industries, the vaccine contract manufacturing market in emerging markets will mainly show growth through domestic demands, at least in the first half of the forecast period, as emerging markets still grapples with international vaccine manufacturing practises and new technology platforms.”

The 155-page report contains 74 charts that add visual analysis in order to explain the developing trends within the Global Vaccine Contract Manufacturing market.

The report provides revenue and growth forecasts to 2027 as well as qualitative analyses for the global vaccine contract manufacturing market

This report also provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the global vaccine market and market shares of the submarkets: paediatric vaccines, adult vaccines, influenza vaccines and therapeutic vaccines.

The 155-page report offers market forecasts for the United States (US), Germany, France, the United Kingdom, Italy, Spain, Japan, China, India, Brazil, Russia and Rest of the World.